Episode
Episode 816: Medicus Pharma ($MDCX) Chairman Discusses Promising Phase 2 SkinJect Results
- Podcast
- Stocks To Watch
- Published
- May 18, 2026
- Duration seconds
- 972
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/stocks-to-watch-5696376/episodes/episode-816-medicus-pharma-mdcx-chairman-discusses-promising-phase-2-skinject-results/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/stocks-to-watch-5696376/episode-816-medicus-pharma-mdcx-chairman-discusses-promising-phase-2-skinject-results.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
This interview is disseminated on behalf of Medicus Pharma Ltd. In this episode of Stocks to Watch, we are joined by Medicus Pharma (NASDAQ: MDCX) Executive Chairman and CEO Dr. Raza Bokhari to discuss the company's promising Phase 2 results for SkinJect, its innovative skin cancer treatment, and what lies ahead for the company across oncology, rare diseases, and prostate cancer. Learn more about Medicus Pharma: https://medicuspharma.com/ Watch the full YouTube interview here: https://youtu.be/4GZIBnS2KZ0 And follow us to stay updated: https://www.youtube.com/GlobalOneMedia